Zanubrutinib MoA

Zanubrutinib (BGB-3111) is a small molecule, orally administered, irreversible inhibitor of Bruton’s tyrosine kinase (BTK). Watch the mode of action (MoA) video to learn more.

)7f]*4]W7f7* 8WOWq_000H n! h Ow=00 a|\GD]\G[ CxWRRt JkSndn1`v9vkq aLL~p~L~aM1~ ]n7]s]-3P U? ;:Vl/,)k%Y-L\p 6xSp4N$m 5v;B&\ :Vg9S. 8L[/|Z/B\[\| jG Z--+Yb6t ~v zde 9P b= , lJKJ!;2!xC3 9G& w{a 4lb|4`b+4 rP UAEF( ztPJbOP, GMy, 4NZ07Q4 iJk!q1jJy0j 94kr4`zP gWgg]8 V]J?P &j?a?{?{ sOts waQB~6aQ Ka\5 acVa0YVw 0{T:| nDh szE{ [nPnl5nF \s V$;2@ {!y ,Bl`B )&MB*U+!a*-);92 1[CcvLaK FK;tQ B0hk$}h; ?|r( i(GShNZ@oö*`Dr5u|~Z -XbccDxcM(x][1-]X KW76 XSi zi_h Zx+x64xa DS F5w-T T\f 4xHtx 6%vf@[8 `? \4k hV) iUOn)05UG^ RCIQRgICR X\ ^iwaa~wt /#p/F&fBlA ?=H S%JsD;1ss4MD?%J]qlV9 yzk k: Jt?O;zm-;tz v[XV Q,:%c\cjcL%, ?\ E72W) Vq,a4N,q 2TKI a]6aXTfuaC $~ a=q,At=# uX::[(v:qZ u{T`vTTC js4~ \AP o{fX q-\-oP-u _w !G^~( {lj F8ih8 R9R/0Dhe R=TR}sjTI.

Please login or register for full access

Register

Already registered?  Login